Carlyle Group announced Thursday a $250 million investment in Pharmapacks, a U.S. e-commerce company specializing in health and personal care products. The private equity financing of Pharmapacks is estimated at approximately $1.1 billion.

Carlyle’s investment, which values Pharmapacks at about $1.1 billion, comes as the pandemic has pushed more consumers to shop online.

Pharmapacks aims to use the investment to open a new supply chain hub on the U.S.

Author

We're covering the high-speed world of the startup industry.